Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.51 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.51 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 6/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29218924 | 1.00 | CYP4F2 (0.51) | CYP4F2CYP4A11NAAAEPHX1TSHR | |
| SCHEMBL27855525 | 0.95 | CYP4F2 (0.50) | CYP4F2CYP4A11NAAAEPHX1TSHR | |
| SCHEMBL27653255 | 0.95 | CYP4F2 (0.50) | CYP4F2CYP4A11NAAAEPHX1TSHR | |
| SCHEMBL27518613 | 0.95 | CYP4F2 (0.50) | CYP4F2CYP4A11NAAAEPHX1TSHR | |
| SCHEMBL611991 | 0.95 | CYP4F2 (0.50) | CYP4F2CYP4A11NAAAEPHX1TSHR | |
| SCHEMBL27872170 | 0.95 | CYP4F2 (0.50) | CYP4F2CYP4A11NAAAEPHX1TSHR | |
| SCHEMBL27526740 | 0.95 | CYP4F2 (0.50) | CYP4F2CYP4A11NAAAEPHX1TSHR | |
| SCHEMBL4277901 | 0.95 | CYP4F2 (0.50) | CYP4F2CYP4A11NAAAEPHX1TSHR | |
| SCHEMBL27855522 | 0.95 | CYP4F2 (0.50) | CYP4F2CYP4A11NAAAEPHX1TSHR | |
| SCHEMBL26959289 | 0.93 | NAAA (0.47) | CYP4F2CYP4A11NAAAEPHX1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0817621-B2 | PHARMACEUTICAL COMPOSITION FOR TRANSDERMIC DELIVERY | SANOFI AVENTIS (FR) | 2007-12-26 | — | — | EP | claimed |
| EP-0817621-B1 | PHARMACEUTICAL COMPOSITION FOR TRANSDERMIC DELIVERY | SANOFI SYNTHELABO (FR) | 2001-06-20 | — | — | EP | claimed |
| EP-4038038-A1 | STABLE AQUEOUS COMPOSITIONS OF FERTILIZER AND AGRICULTURALLY ACTIVE COMPOUND | BASF SE (DE) | 2022-08-10 | — | — | EP | disclosed |
| WO-2021063885-A1 | STABLE AQUEOUS COMPOSITIONS OF FERTILIZER AND AGRICULTURALLY ACTIVE COMPOUND | BASF SE (DE) | 2021-04-08 | — | — | WO | disclosed |
| US-9072676-B2 | Cyclohexyl carbamate compounds as skin and/or hair lightening actives | SYMRISE AG (DE) | 2015-07-07 | — | — | US | disclosed |
| US-20130156710-A1 | CYCLOHEXYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES | SYMRISE AG (DE) | 2013-06-20 | — | — | US | disclosed |
| EP-1818060-A1 | Cosmetic composition comprising Fadogia ancylantha extracts | ARTSANA S.p.A. (IT) | 2007-08-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130156710-A1 | CYCLOHEXYL CARBAMATE COMPOUNDS AS SKIN AND/OR HAIR LIGHTENING ACTIVES | CBR1, CYP2A13, CBR3 | CYP4F2 79/4885CYP4A11 55/4885NAAA 1221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.